Autobio Diagnostics Co Ltd (603658) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.049x

Based on the latest financial reports, Autobio Diagnostics Co Ltd (603658) has a cash flow conversion efficiency ratio of 0.049x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥435.24 Million ≈ $63.69 Million USD) by net assets (CN¥8.85 Billion ≈ $1.29 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 603658 equity to assets ratio to measure how much of total assets are equity-financed.

Autobio Diagnostics Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Autobio Diagnostics Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Autobio Diagnostics Co Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.

Autobio Diagnostics Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Autobio Diagnostics Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Brookfield Wealth Solutions Ltd. NYSE:BNT	0.026x
Ratch Group Public Company Limited BK:RATCH	0.054x
CREDITACCESS GRAMEEN LIMITED NSE:CREDITACC	0.043x
Worthington Industries Inc NYSE:WOR	0.053x
Harley-Davidson Inc NYSE:HOG	-0.074x
CJ Corp KO:001040	0.099x
Greenland Holdings Corp Ltd SHG:600606	0.021x
Transmissora Aliança de Energia Elétrica S.A SA:TAEE11	0.086x

Annual Cash Flow Conversion Efficiency for Autobio Diagnostics Co Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Autobio Diagnostics Co Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see Autobio Diagnostics Co Ltd stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥8.69 Billion ≈ $1.27 Billion	CN¥1.31 Billion ≈ $191.59 Million	0.151x	-11.19%
2023-12-31	CN¥8.67 Billion ≈ $1.27 Billion	CN¥1.47 Billion ≈ $215.09 Million	0.170x	-13.89%
2022-12-31	CN¥7.91 Billion ≈ $1.16 Billion	CN¥1.56 Billion ≈ $228.05 Million	0.197x	-0.21%
2021-12-31	CN¥7.40 Billion ≈ $1.08 Billion	CN¥1.46 Billion ≈ $213.82 Million	0.197x	+30.67%
2020-12-31	CN¥6.59 Billion ≈ $963.64 Million	CN¥994.71 Million ≈ $145.56 Million	0.151x	-52.79%
2019-12-31	CN¥2.63 Billion ≈ $385.52 Million	CN¥842.89 Million ≈ $123.34 Million	0.320x	-3.79%
2018-12-31	CN¥1.97 Billion ≈ $287.67 Million	CN¥653.73 Million ≈ $95.66 Million	0.333x	+16.62%
2017-12-31	CN¥1.69 Billion ≈ $247.22 Million	CN¥481.73 Million ≈ $70.49 Million	0.285x	+12.80%
2016-12-31	CN¥1.64 Billion ≈ $240.70 Million	CN¥415.82 Million ≈ $60.85 Million	0.253x	-41.15%
2015-12-31	CN¥718.55 Million ≈ $105.15 Million	CN¥308.63 Million ≈ $45.16 Million	0.430x	-16.26%
2014-12-31	CN¥500.94 Million ≈ $73.30 Million	CN¥256.93 Million ≈ $37.60 Million	0.513x	+69.15%
2013-12-31	CN¥340.42 Million ≈ $49.81 Million	CN¥103.22 Million ≈ $15.10 Million	0.303x	+2.28%
2012-12-31	CN¥233.84 Million ≈ $34.22 Million	CN¥69.32 Million ≈ $10.14 Million	0.296x	-8.02%
2011-12-31	CN¥156.96 Million ≈ $22.97 Million	CN¥50.59 Million ≈ $7.40 Million	0.322x	--

About Autobio Diagnostics Co Ltd

SHG:603658 China Medical Devices

Market Cap

$2.68 Billion

CN¥18.29 Billion CNY

Market Cap Rank

#5259 Global

#929 in China

Share Price

CN¥32.01

Change (1 day)

-1.99%

52-Week Range

CN¥28.72 - CN¥42.46

All Time High

CN¥131.73